These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15588447)

  • 21. Falsely elevated cardiac troponin-I in patients with seropositive rheumatoid arthritis.
    Kenny PR; Finger DR
    J Rheumatol; 2005 Jul; 32(7):1258-61. PubMed ID: 15996061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Using troponins in the correct way].
    Babuin L; Iliceto S; Jaffe AS
    G Ital Cardiol (Rome); 2007 Jun; 8(6):382-4. PubMed ID: 17633914
    [No Abstract]   [Full Text] [Related]  

  • 23. Refining our criteria: a critical challenge.
    Jaffe AS; Apple FS
    Am J Clin Pathol; 2009 Jan; 131(1):11-3. PubMed ID: 19095560
    [No Abstract]   [Full Text] [Related]  

  • 24. False positive analytical interference of cardiac troponin I assays: an important consideration for method selection.
    Parry DM; Krahn J; Leroux M; Dalton J
    Clin Biochem; 1999 Nov; 32(8):667-9. PubMed ID: 10638952
    [No Abstract]   [Full Text] [Related]  

  • 25. The determination of the 99th centile level for troponin assays in an Australian reference population.
    Tate JR; Ferguson W; Bais R; Kostner K; Marwick T; Carter A
    Ann Clin Biochem; 2008 May; 45(Pt 3):275-88. PubMed ID: 18482916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troponin levels in hemodialysis patients: interpretation based on guidelines, changing concentrations and high-sensitivity assays.
    Kavsak PA
    Nephrol Dial Transplant; 2011 Mar; 26(3):1112-3. PubMed ID: 21220754
    [No Abstract]   [Full Text] [Related]  

  • 27. The challenges and concerns companies face pertaining to the US Food and Drug Administration 510(k) process for cardiac biomarkers.
    Apple FS; Morrow D; Zaugg C; Hickey D; Zaharik M; Blackwood JJ; Jakobsen K
    Clin Chem; 2012 Jan; 58(1):31-8. PubMed ID: 22096032
    [No Abstract]   [Full Text] [Related]  

  • 28. Interpretation of high sensitivity cardiac troponin I results: reference to biological variability in patients who present to the emergency room with chest pain: case report series.
    Wu AH
    Clin Chim Acta; 2009 Mar; 401(1-2):170-4. PubMed ID: 19135041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
    Venge P; Johnston N; Lindahl B; James S
    J Am Coll Cardiol; 2009 Sep; 54(13):1165-72. PubMed ID: 19761938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent cardiac troponin-I screening is an effective means of surveillance for a perioperative myocardial infarction.
    Martinez EA; Nass CM; Jermyn RM; Rosenbaum SH; Akhtar S; Chan DW; Malkus H; Weiss JL; Fleisher LA
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):577-82. PubMed ID: 16202889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Troponin assays for the diagnosis of myocardial infarction and acute coronary syndrome: where do we stand?
    Eisenman A
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):509-14. PubMed ID: 16918269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outlier removal methods for skewed data: impact on age-specific high-sensitive cardiac troponin T 99th percentiles.
    Monneret D; Gellerstedt M; Roche F; Bonnefont-Rousselot D
    Clin Chem Lab Med; 2019 Sep; 57(10):e244-e247. PubMed ID: 30860976
    [No Abstract]   [Full Text] [Related]  

  • 34. The diagnostic value of troponin T testing in the community setting.
    Planer D; Leibowitz D; Paltiel O; Boukhobza R; Lotan C; Weiss TA
    Int J Cardiol; 2006 Mar; 107(3):369-75. PubMed ID: 15964644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiac troponin I and C: analytical comparison and clinical-biological interpretation of three troponins assays].
    Bionda C; Pettazzoni M; Rodriguez-Lafrasse C; Ardail D; Rousson R
    Ann Biol Clin (Paris); 2005; 63(2):185-92. PubMed ID: 15771976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carryover does not affect results of Beckman Coulter highly-sensitive-AccuTnI assay on Access 2.
    Lippi G; Avanzini P; Musa R; Aloe R; Cervellin G
    Clin Chem Lab Med; 2013 Jul; 51(7):e141-3. PubMed ID: 23337056
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac troponin monitoring for detection of myocardial infarction: newer generation assays are here to stay.
    Apple FS
    Clin Chim Acta; 2007 May; 380(1-2):1-3; discussion 245-6. PubMed ID: 17306782
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome.
    Brunet P; Oddoze C; Paganelli F; Indreies M; Faure V; Opris-Saveanu A; Morange S; Portugal H; Dussol B; Berland Y
    Int J Cardiol; 2008 Sep; 129(2):205-9. PubMed ID: 17662483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The standardization of troponin I assays: an update.
    Rogers LC
    MLO Med Lab Obs; 2004 Jan; 36(1):24. PubMed ID: 14758601
    [No Abstract]   [Full Text] [Related]  

  • 40. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction.
    Apple FS; Parvin CA; Buechler KF; Christenson RH; Wu AH; Jaffe AS
    Clin Chem; 2005 Nov; 51(11):2198-200. PubMed ID: 16244304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.